Filing Flows › AtriCure (ATRC) › Q2 2025
AtriCure (ATRC) Q2 2025 earnings results (second quarter 2025)
10-Q filed Jul 30, 2025
AtriCure (ATRC) reported revenue of $136M for the second quarter 2025 (Q2 2025), +17% from a year earlier and +10% from the quarter before. Operating margin was -4.5%, net loss $6.2M (4.5% of revenue).
AtriCure, Q2 2025: revenue $136M (+17% year over year), operating margin -4.5%, net loss $6.2M, operating cash flow $21.6M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $136M | +10% | +17% |
| Operating profit | −$6.2M | — | — |
| Net earnings | −$6.2M | — | — |
| Operating cash flow | $21.6M | — | +193% |
| Free cash flow | $19.0M | — | +279% |
What changed
Revenue was $136.1M in Q2 2025, up 17% year over year and up 10% from the previous quarter.
Gross margin was 74.5%, down 0.1 points from a year earlier. Operating costs exceeded revenue by $6.2M, an operating margin of -4.5%. Operating expenses grew 15% against revenue growth of 17%. The fastest-growing cost line was Research & development (+43%). The quarter ended with a net loss of $6.2M, narrower than the previous quarter's $6.7M loss.
Operating cash flow was $21.6M (up 193% year over year). Non-cash charges added back $5.2M of depreciation and amortization and $11.4M of share-based compensation. Working capital and other items added $11.3M. Capital expenditures of $2.7M left free cash flow of $19.0M.
Questions
What was AtriCure's revenue in the second quarter 2025?
AtriCure (ATRC) reported revenue of $136M for the second quarter 2025 (Q2 2025), +17% from a year earlier and +10% from the quarter before.
Was AtriCure profitable in the second quarter 2025?
Operating loss was $6.2M (-4.5% of revenue) and net loss $6.2M.
Source: AtriCure 10-Q on SEC EDGAR.